-
1
المؤلفون: Karnevi, E., Dror, L. B., Mardinoglu, Adil, Elebro, J., Heby, M., Olofsson, S. -E, Nodin, B., Eberhard, J., Gallagher, W., Uhlén, Mathias, Jirström, K.
المصدر: Oncotarget. 9(5):6188-6200
مصطلحات موضوعية: Pancreatic cancer, Periampullary cancer, Prediction, Prognosis, RBM3, antineoplastic agent, cyclooxygenase 2, gemcitabine, interleukin 8, messenger RNA, RNA binding motif protein 3, RNA binding protein, small interfering RNA, unclassified drug, adult, aged, Article, cancer adjuvant therapy, cancer prognosis, cell migration, cell motility, cell viability, cohort analysis, controlled study, drug resistance, drug sensitivity, female, fetus, human, human cell, human tissue, in vitro study, lymph node metastasis, major clinical study, male, overall survival, pancreas cancer, pancreatic cancer cell line, pancreaticoduodenectomy, periampullary adenocarcinoma, predictive value, protein expression, protein function, recurrence free survival, retrospective study, translational research, tumor invasion
وصف الملف: print